A Johnson & Johnson acquisition of Boston Scientific would be a “good fit” that would accelerate medtech growth, according to analysts at Needham.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,